SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-042920
Filing Date
2024-05-14
Accepted
2024-05-14 16:05:42
Documents
55
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0205785-10q_citius.htm   iXBRL 10-Q 543276
2 CERTIFICATION ea020578501ex31-1_citius.htm EX-31.1 10517
3 CERTIFICATION ea020578501ex31-2_citius.htm EX-31.2 10959
4 CERTIFICATION ea020578501ex32-1_citius.htm EX-32.1 5193
  Complete submission text file 0001213900-24-042920.txt   3584001

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ctxr-20240331.xsd EX-101.SCH 43445
6 XBRL CALCULATION FILE ctxr-20240331_cal.xml EX-101.CAL 26033
7 XBRL DEFINITION FILE ctxr-20240331_def.xml EX-101.DEF 175076
8 XBRL LABEL FILE ctxr-20240331_lab.xml EX-101.LAB 334536
9 XBRL PRESENTATION FILE ctxr-20240331_pre.xml EX-101.PRE 171983
59 EXTRACTED XBRL INSTANCE DOCUMENT ea0205785-10q_citius_htm.xml XML 305482
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 24944231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)